Protagenic Therapeutics
NASDAQ: PTIX
Healthcare
Biotechnology
Rank
#45948
Market Cap
1.56 M
Volume
481,911
Price
2.90
Change (%)
7.50%
Country or region
United States
United States
Protagenic Therapeutics's latest marketcap:
1.56 M
As of May 6, 2025, Protagenic Therapeutics's market capitalization has reached $1.56 M. According to our data, Protagenic Therapeutics is the 45948th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.56 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -5,525,344 |
| Shares Out | 537,548 |
| EPS (ttm) | -15.79 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 14, 2025 |
Market Cap Chart
Data Updated: May 6, 2025
Protagenic Therapeutics's yearly market capitalization.
Protagenic Therapeutics has seen its market value drop from $10.88 M to $1.56 M since 2020, representing a total decrease of 85.67% and an annual compound decline rate (CAGR) of 35.07%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 6, 2025 | $1.56 M | -49.39% |
| December 31, 2024 | $3.33 M | -24.17% |
| December 29, 2023 | $4.39 M | -36.5% |
| December 30, 2022 | $6.91 M | -70.56% |
| December 31, 2021 | $23.48 M | 115.87% |
| November 5, 2020 | $10.88 M |
Company Profile
Frequently Asked Questions
As of May 6, 2025, Protagenic Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $1.56 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Protagenic Therapeutics global market capitalization ranking is approximately 45948 as of May 6, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 1994 |
| IPO Date | January 5, 2016 |
| Employees | 3 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |